Peter Armenio Joins White & Case as a Partner in New York

Press Release
1 min read

Global law firm White & Case LLP has expanded its Global Intellectual Property Practice with the addition of Peter Armenio, a leading intellectual property and life sciences patent litigator, as a partner in New York.

"Peter is a highly skilled and respected patent litigator, with impressive first-chair trial credentials that complement the word-class capabilities of our IP team," said Anita Varma, White & Case's Global Head of Intellectual Property. "We're experiencing a surge of patent litigation mandates in the life sciences sector. With the addition of Peter's market-leading experience, we are further uniquely positioned to guide clients through all aspects of patent litigation and disputes in the pharma, biotech, and medical device sectors of the life sciences industry."

Armenio joins White & Case from Quinn Emanuel Urquhart & Sullivan, where he was a partner and co-head of its global life sciences practice. He has extensive experience advising on patent litigation and counseling on matters regarding pharmaceuticals, biologics, medical devices, and DNA diagnostic and sequencing technologies, as well as a wide range of other patent and general commercial matters in courts across the US, and in national and international arbitrations. He has represented a range of clients from Fortune 100 companies to startups, including clients based in the US, Europe and Asia-Pacific.

"White & Case's capabilities in the life sciences sector are unmatched, and Peter's addition cements our IP team as a central and formidable feature of our leading practice," said Jack Pace, the Head of White & Case's Competition Section for the Americas. "As pharmaceutical, biotech, and medtech clients face more and more complex patent litigation challenges, Peter's extraordinary record in high-stakes disputes will be a necessary resource for our clients. He is an exceptional addition to our team."

Press contact
For more information please speak to your local media contact.